Gainers
- ADMA Biologics ADMA shares moved upwards by 11.42% to $1.56 during Thursday's pre-market session. The market value of their outstanding shares is at $305.4 million. As per the press release, Q3 earnings came out yesterday.
- Dynatronics DYNT shares rose 9.33% to $1.64. The company's market cap stands at $28.8 million. As per the news, the Q1 earnings report came out today.
- Erytech Pharma ERYP shares increased by 8.69% to $2.5. The company's market cap stands at $69.8 million.
- AnPac Bio-Medical Science ANPC stock moved upwards by 8.28% to $1.7. The market value of their outstanding shares is at $23.9 million.
- Repro-Med Systems KRMD stock rose 8.15% to $3.05. The market value of their outstanding shares is at $135.7 million. As per the press release, Q3 earnings came out yesterday.
- UpHealth UPH shares moved upwards by 7.37% to $2.62. The market value of their outstanding shares is at $368.8 million. The company's, Q3 earnings came out yesterday.
Losers
- Schrodinger SDGR shares decreased by 15.37% to $43.3 during Thursday's pre-market session. The market value of their outstanding shares is at $3.0 billion. As per the press release, Q3 earnings came out yesterday.
- Cumberland CPIX shares declined by 8.69% to $2.63. The company's market cap stands at $39.1 million. As per the news, the Q3 earnings report came out 2 days ago.
- Progenity PROG stock fell 8.53% to $3.22. The company's market cap stands at $427.4 million. The company's, Q3 earnings came out yesterday.
- FIGS FIGS stock declined by 7.65% to $36.0. The market value of their outstanding shares is at $5.7 billion. As per the press release, Q3 earnings came out yesterday.
- Calliditas Therapeutics CALT stock declined by 7.21% to $16.75. The company's market cap stands at $438.3 million.
- MorphoSys MOR shares declined by 4.81% to $10.49. The market value of their outstanding shares is at $1.4 billion. As per the press release, Q3 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in